pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidons - idiopātiska plaušu fibroze - imūnsupresanti - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
pirfenidone viatris
viatris limited - pirfenidons - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imūnsupresanti - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
pirfenidone accord 267 mg apvalkotās tabletes
accord healthcare b.v., netherlands - pirfenidons - apvalkotā tablete - 267 mg
pirfenidone accord 801 mg apvalkotās tabletes
accord healthcare b.v., netherlands - pirfenidons - apvalkotā tablete - 801 mg
pirfenidone zentiva 801 mg apvalkotās tabletes
zentiva, k.s., czech republic - pirfenidons - apvalkotā tablete - 801 mg
pirfenidone umedica 267 mg apvalkotās tabletes
umedica netherlands b.v., netherlands - pirfenidons - apvalkotā tablete - 267 mg
pirfenidone umedica 801 mg apvalkotās tabletes
umedica netherlands b.v., netherlands - pirfenidons - apvalkotā tablete - 801 mg
pirfenidone teva 801 mg apvalkotās tabletes
teva gmbh, germany - pirfenidons - apvalkotā tablete - 801 mg
esbriet
roche registration gmbh - pirfenidons - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imūnsupresanti - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
ofev
boehringer ingelheim international gmbh - nintedanib - idiopātiska plaušu fibroze - antineoplastiski līdzekļi - ofev ir indicēts pieaugušajiem idiopātiskā plaušu fibrozes (ipf) ārstēšanai.